Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (371-380 of 443) with videos related to

Pageof 45
Sort By:
Cancer Research|July 18, 2023
GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent MannerZijing Wang, Nan Zhang, Miao Zhang, et al.
The Journal of Pathology|May 21, 2011
Notch3 signalling promotes tumour growth in colorectal cancerValentina Serafin, Luca Persano, Lidia Moserle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinomaJohanna K Thurlow, Claudia L Peña Murillo, Keith D Hunter, et al.
Journal of the National Cancer Institute|May 1, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastomaJun Yang, Alaa M AlTahan, Dongli Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsChristy C Ong, Adrian M Jubb, Peter M Haverty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsAlberto Bottini, Daniele Generali, Maria Pia Brizzi, et al.
European Journal of Radiology|March 29, 2020
Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: Comparison with histological subregions and impact on pharmacokinetic parameter analysisJames M Franklin, Benjamin Irving, Bartlomiej W Papiez, et al.
British Journal of Cancer|February 14, 2018
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424Victoria K Woodcock, Sally Clive, Richard H Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2012
Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinomaGuy N J Betts, Amanda Eustace, Shalini Patiar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
Pageof 45

Showing results (371-380 of 443) with videos related to

Sort By:
Pageof 45
Cancer Research|July 18, 2023
GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent MannerZijing Wang, Nan Zhang, Miao Zhang, et al.
The Journal of Pathology|May 21, 2011
Notch3 signalling promotes tumour growth in colorectal cancerValentina Serafin, Luca Persano, Lidia Moserle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinomaJohanna K Thurlow, Claudia L Peña Murillo, Keith D Hunter, et al.
Journal of the National Cancer Institute|May 1, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastomaJun Yang, Alaa M AlTahan, Dongli Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsChristy C Ong, Adrian M Jubb, Peter M Haverty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsAlberto Bottini, Daniele Generali, Maria Pia Brizzi, et al.
European Journal of Radiology|March 29, 2020
Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: Comparison with histological subregions and impact on pharmacokinetic parameter analysisJames M Franklin, Benjamin Irving, Bartlomiej W Papiez, et al.
British Journal of Cancer|February 14, 2018
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424Victoria K Woodcock, Sally Clive, Richard H Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2012
Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinomaGuy N J Betts, Amanda Eustace, Shalini Patiar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
Pageof 45